ATG 037
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ATG 037, covering 2025-06-09 to 2025-06-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors [Phase 1]